We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Preclinical Modeling of Tumor Metastasis and Resistance: Current Challenges and New Approaches

Article   Apr 15, 2019 | by Fiona Nielsen, CEO of Repositive

 
Preclinical Modeling of Tumor Metastasis and Resistance: Current Challenges and New Approaches
 
 
 

RELATED ARTICLES

The First Winners of the LEA

Article

The Lipidomics Excellence Award (LEA) was founded to strengthen life sciences through lipidomics. After reviewing the many high-quality submitted projects, the LEA jury has announced the three awardees.

READ MORE

The Evolution of Proteomics - Dr Evangelia Petsalaki

Article

Dr Evangelia Petsalaki is a Group Leader at the European Bioinformatics Group, where her research team study human cell signaling in health and disease conditions. Collaborating with teams specializing in MS, imaging and cell biology, their aim is to make both predictive and conditional models so they can anticipate what might happen in a biological network under different conditions.

READ MORE

The Evolution of Proteomics – Professor Ruedi Aebersold

Article

Kicking off "The Evolution of Proteomics" series is a pioneer of proteomics, Professor Ruedi Aebersold. Aebersold's research in quantitative proteomics has helped shape our understanding of how proteins function, interact and are localized in both normal and diseased states.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE